Evidence map›Paper›PMID 24955077›Full record

ArticlePediatric rheumatology online journal2014

Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort.

Heidi S Szugye, Andrew S Zeft, Steven J Spalding

Open access · goldAbstract read
In one paragraph

Article in Pediatric rheumatology online journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Real-World Biomarkers for Pediatric Takayasu Arteritis.International journal of molecular sciences · 2024
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Recent Advances in Pediatric Vasculitis.Rheumatic diseases clinics of North America · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Morbidity and Mortality of Large-Vessel Vasculitides.Current rheumatology reports · 2020
    Review
  16. Article
  17. Review
  18. Childhood-onset Takayasu Arteritis.European journal of rheumatology · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Heidi S SzugyeCleveland Clinic Children's, Cleveland, Ohio, USA.
Andrew S ZeftCenter for Pediatric Rheumatology, Cleveland Clinic Children's, Cleveland, Ohio, USA.
Steven J SpaldingCenter of Pediatric Rheumatology, Center for Pediatric Rheumatology, Cleveland Clinic Children's, 9500 Euclid Avenue/Desk A111, Cleveland, OH 44195, USA.
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTakayasu Arteritis is an idiopathic, chronic, large vessel vasculitis involving the aorta and its primary branches. Few studies have been done in pediatric patients to date with the largest case series of US patients published in 2003 consisting of only 6 patients.

methodsA retrospective chart review was performed on all patients seen at Cleveland Clinic Children's up until 2012 who met EULAR/PRINTO/PRES classification criteria for childhood Takayasu Arteritis.

resultsTwenty-one patients with a mean follow up of 2.3 years were studied. Weight loss, fatigue, and anorexia were the most common presenting complaints. 57.1% of patients were hypertensive at first visit. The most common examintation finding was diminished pulses (61.9%), followed by bruits, and then murmurs. Thoracic aorta stenosis was the most common vascular abnormality. Seven of twenty-one patients responded well to methotrexate and prednisone alone. Ten of twenty-one patients required an additional medication for symptom and disease control (infliximab most commonly). About two-thirds of patients required at least one anti-hypertensive medication. Eight of the twenty-one patients required surgical intervention for severe disease refractory to medications (renal artery stenosis being the most common indication). Almost all patients reported symptomatic improvement after surgical intervention. Two of the eight patients required a second surgery for return of symptoms. Disease sequelae included arterial aneurysms, resolved heart failure, and hypertensive emergencies.

conclusionOur study emphasizes that constitutional symptoms coupled with objective findings of diminished pulses, bruits, and hypertension should raise clinical suspicion for Takayasu Arteritis in pediatric patients. Pharmacologic therapy alone can be successful in controlling disease progression, however surgery was successful in minimizing symptoms when medical therapies failed.

Indexed as

AortaHypertensionTakayasu ArteritisAdolescentAntibodies, MonoclonalAntirheumatic AgentsAortographyChildCohort StudiesConstriction, PathologicFemaleHumansInfliximabMaleMethotrexatePrednisoneAntibodies, MonoclonalAntirheumatic AgentsInfliximabMethotrexatePrednisoneTumor Necrosis Factor-alphaChildrenCleveland Clinic Children’s Center for Pediatric RheumatologyTakayasu ArteritisUnited StatesVasculitis

Identifiers

PMID24955077
PMCPMC4065084
OpenAlexW2112948605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.